Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82,051,282
-
Total 13F shares
-
69,502,343
-
Share change
-
-1,166,941
-
Total reported value
-
$904,301,498
-
Put/Call ratio
-
176%
-
Price per share
-
$13.01
-
Number of holders
-
137
-
Value change
-
-$23,098,956
-
Number of buys
-
86
-
Number of sells
-
43
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q2 2024
As of 30 Jun 2024,
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,502,343 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., Deep Track Capital, LP, VR Adviser, LLC, VANGUARD GROUP INC, MAVERICK CAPITAL LTD, Paradigm Biocapital Advisors LP, STATE STREET CORP, COMMODORE CAPITAL LP, and Novo Holdings A/S.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.